These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

390 related articles for article (PubMed ID: 30400344)

  • 21. Characterization of Lysozyme-Like Effector TseP Reveals the Dependence of Type VI Secretion System (T6SS) Secretion on Effectors in Aeromonas dhakensis Strain SSU.
    Liang X; Pei TT; Wang ZH; Xiong W; Wu LL; Xu P; Lin S; Dong TG
    Appl Environ Microbiol; 2021 May; 87(12):e0043521. PubMed ID: 33837015
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diverse NADase effector families mediate interbacterial antagonism via the type VI secretion system.
    Tang JY; Bullen NP; Ahmad S; Whitney JC
    J Biol Chem; 2018 Feb; 293(5):1504-1514. PubMed ID: 29237732
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Breadth and Molecular Basis of Hcp-Driven Type VI Secretion System Effector Delivery.
    Howard SA; Furniss RCD; Bonini D; Amin H; Paracuellos P; Zlotkin D; Costa TRD; Levy A; Mavridou DAI; Filloux A
    mBio; 2021 Jun; 12(3):e0026221. PubMed ID: 34061601
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparative genomics methodology reveals a widespread family of membrane-disrupting T6SS effectors.
    Fridman CM; Keppel K; Gerlic M; Bosis E; Salomon D
    Nat Commun; 2020 Feb; 11(1):1085. PubMed ID: 32109231
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MIX and match: mobile T6SS MIX-effectors enhance bacterial fitness.
    Salomon D
    Mob Genet Elements; 2016; 6(1):e1123796. PubMed ID: 27066305
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Type VI secretion system: a modular toolkit for bacterial dominance.
    Jana B; Salomon D
    Future Microbiol; 2019 Nov; 14():1451-1463. PubMed ID: 31718312
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PAAR-Rhs proteins harbor various C-terminal toxins to diversify the antibacterial pathways of type VI secretion systems.
    Ma J; Sun M; Dong W; Pan Z; Lu C; Yao H
    Environ Microbiol; 2017 Jan; 19(1):345-360. PubMed ID: 27871130
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chimeric adaptor proteins translocate diverse type VI secretion system effectors in Vibrio cholerae.
    Unterweger D; Kostiuk B; Ötjengerdes R; Wilton A; Diaz-Satizabal L; Pukatzki S
    EMBO J; 2015 Aug; 34(16):2198-210. PubMed ID: 26194724
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of divergent type VI secretion effectors using a conserved chaperone domain.
    Liang X; Moore R; Wilton M; Wong MJ; Lam L; Dong TG
    Proc Natl Acad Sci U S A; 2015 Jul; 112(29):9106-11. PubMed ID: 26150500
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Salmonella Typhimurium utilizes a T6SS-mediated antibacterial weapon to establish in the host gut.
    Sana TG; Flaugnatti N; Lugo KA; Lam LH; Jacobson A; Baylot V; Durand E; Journet L; Cascales E; Monack DM
    Proc Natl Acad Sci U S A; 2016 Aug; 113(34):E5044-51. PubMed ID: 27503894
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The T6SSs of Pseudomonas aeruginosa Strain PAO1 and Their Effectors: Beyond Bacterial-Cell Targeting.
    Sana TG; Berni B; Bleves S
    Front Cell Infect Microbiol; 2016; 6():61. PubMed ID: 27376031
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systematic Identification and Analysis of
    Lewis JM; Deveson Lucas D; Harper M; Boyce JD
    Front Microbiol; 2019; 10():2440. PubMed ID: 31736890
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Type VI Secretion Effectors: Methodologies and Biology.
    Lien YW; Lai EM
    Front Cell Infect Microbiol; 2017; 7():254. PubMed ID: 28664151
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Formylglycine-Generating Enzyme-Like Proteins Constitute a Novel Family of Widespread Type VI Secretion System Immunity Proteins.
    Lopez J; Le NH; Moon KH; Salomon D; Bosis E; Feldman MF
    J Bacteriol; 2021 Oct; 203(21):e0028121. PubMed ID: 34398661
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Transcriptional Regulatory Mechanism Finely Tunes the Firing of Type VI Secretion System in Response to Bacterial Enemies.
    Lazzaro M; Feldman MF; García Véscovi E
    mBio; 2017 Aug; 8(4):. PubMed ID: 28830939
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Engineered Type Six Secretion Systems Deliver Active Exogenous Effectors and Cre Recombinase.
    Hersch SJ; Lam L; Dong TG
    mBio; 2021 Aug; 12(4):e0111521. PubMed ID: 34281388
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibacterial T6SS effectors with a VRR-Nuc domain are structure-specific nucleases.
    Hespanhol JT; Sanchez-Limache DE; Nicastro GG; Mead L; Llontop EE; Chagas-Santos G; Farah CS; de Souza RF; Galhardo RDS; Lovering AL; Bayer-Santos E
    Elife; 2022 Oct; 11():. PubMed ID: 36226828
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An Overview of Anti-Eukaryotic T6SS Effectors.
    Monjarás Feria J; Valvano MA
    Front Cell Infect Microbiol; 2020; 10():584751. PubMed ID: 33194822
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of Vibrio cholerae genomes identifies new type VI secretion system gene clusters.
    Crisan CV; Chande AT; Williams K; Raghuram V; Rishishwar L; Steinbach G; Watve SS; Yunker P; Jordan IK; Hammer BK
    Genome Biol; 2019 Aug; 20(1):163. PubMed ID: 31405375
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    Tchelet D; Keppel K; Bosis E; Salomon D
    Gut Microbes; 2023; 15(1):2178795. PubMed ID: 36803660
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.